Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein
- PMID: 23953221
- DOI: 10.1016/j.jbspin.2013.06.013
Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein
Abstract
Erdheim-Chester disease is a rare non-langerhans systemic histiocytosis of unknown origin, associated with bone diseases and severe visceral complications. Therapies have been disappointing. A recombinant form of interleukin-1 receptor antagonist (anakinra) has been used in a few cases when usual treatment fails. We report a new case of successfully interleukin-1 receptor antagonist treatment in Erdheim-Chester disease.
Keywords: Anakinra; Erdheim-Chester disease; Histiocytosis; Interleukin-1 receptor antagonist protein.
Copyright © 2013 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
